BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27822025)

  • 1. Deep analyses of the associations of a series of biomarkers with insulin resistance, metabolic syndrome, and diabetes risk in nondiabetic middle-aged and elderly individuals: results from a Chinese community-based study.
    Fu S; Ping P; Luo L; Ye P
    Clin Interv Aging; 2016; 11():1531-1538. PubMed ID: 27822025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of amino-terminal pro-brain natriuretic peptide with metabolic syndrome.
    Li WY; Chiu FC; Chien YF; Lin JW; Hwang JJ
    Intern Med; 2011; 50(11):1143-7. PubMed ID: 21628927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of metabolic syndrome and diabetes mellitus on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with coronary artery disease.
    Huang FY; Peng Y; Deng XX; Huang BT; Xia TL; Gui YY; Liu RS; Yang Y; Pu XB; Chen SJ; Chen F; Zhu Y; Chen M
    Coron Artery Dis; 2017 Mar; 28(2):159-165. PubMed ID: 28045698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-marker and multi-marker approaches to appraise the relationships between biomarkers and microalbuminuria in Chinese middle-aged and elderly from communities: a cross-sectional analysis.
    Fu S; Guo Y; Zhang Z; Luo L; Ye P
    BMC Nephrol; 2018 Apr; 19(1):93. PubMed ID: 29685109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study.
    Baldassarre S; Fragapani S; Panero A; Fedele D; Pinach S; Lucchiari M; Vitale AR; Mengozzi G; Gruden G; Bruno G
    Cardiovasc Diabetol; 2017 Sep; 16(1):119. PubMed ID: 28946871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of N-terminal pro brain natriuretic peptide are enhanced in people with the uncomplicated metabolic syndrome: a case-cohort analysis of the population-based Casale Monferrato study.
    Bruno G; Barutta F; Landi A; Pinach S; Caropreso P; Mengozzi G; Baldassarre S; Fragapani S; Civera S; Cavallo Perin P; Gruden G
    Diabetes Metab Res Rev; 2015 May; 31(4):360-7. PubMed ID: 25370350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-Neurotensin/Neuromedin N and Risk of Incident Metabolic Syndrome and Diabetes Mellitus in the REGARDS Cohort.
    Nicoli CD; Carson AP; Plante TB; Leann Long D; McClure LA; Schulte J; Cushman M
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3483-e3494. PubMed ID: 34013344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between plasma homocysteine level and lipid profiles in a community-based Chinese population.
    Momin M; Jia J; Fan F; Li J; Dou J; Chen D; Huo Y; Zhang Y
    Lipids Health Dis; 2017 Mar; 16(1):54. PubMed ID: 28288621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse Association of N-terminal Pro‒B-type Natriuretic Peptide Level With Metabolic Syndrome in Kidney Transplant Patients.
    Lee KM; Lee MC; Lee CJ; Chen YC; Hsu BG
    Transplant Proc; 2018 Oct; 50(8):2496-2501. PubMed ID: 30316385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese men.
    Zhang X; Zeng X; Liu Y; Dong L; Zhao X; Qu X
    Urol Int; 2014; 93(2):214-9. PubMed ID: 24862628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects.
    Mirhafez SR; Ebrahimi M; Saberi Karimian M; Avan A; Tayefi M; Heidari-Bakavoli A; Parizadeh MR; Moohebati M; Azarpazhooh MR; Esmaily H; Nematy M; Safarian M; Ferns GA; Ghayour-Mobarhan M
    Eur J Clin Nutr; 2016 Nov; 70(11):1298-1304. PubMed ID: 27460263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross sectional study comparing traditional risk factors with N-terminal pro-BNP in high risk groups for cardiovascular disease in Trinidad, West Indies.
    Shivananda Nayak B; Teelucksingh S; Jagessar A; Maharaj S; Maharaj N
    Diabetes Metab Syndr; 2013; 7(1):8-11. PubMed ID: 23517788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is measurement of non-HDL cholesterol an effective way to identify the metabolic syndrome?
    Liu A; Reaven GM
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1122-7. PubMed ID: 23352957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active acromegaly is associated with decreased hs-CRP and NT-proBNP serum levels: insights from the Belgian registry of acromegaly.
    Verhelst J; Velkeniers B; Maiter D; Haentjens P; T'Sjoen G; Rietzschel E; Corvilain B; Abrams P; Nobels F; Abs R; Bex M
    Eur J Endocrinol; 2013 Feb; 168(2):177-84. PubMed ID: 23132698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children.
    Özalp Kızılay D; Şen S; Ersoy B
    J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):262-269. PubMed ID: 30759960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone, C-reactive protein, and plasma B-type natriuretic peptide are associated with the development of metabolic syndrome and longitudinal changes in metabolic syndrome components: findings from the Jackson Heart Study.
    Musani SK; Vasan RS; Bidulescu A; Liu J; Xanthakis V; Sims M; Gawalapu RK; Samdarshi TE; Steffes M; Taylor HA; Fox ER
    Diabetes Care; 2013 Oct; 36(10):3084-92. PubMed ID: 23757435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults.
    Kawamoto R; Tabara Y; Kohara K; Miki T; Kusunoki T; Takayama S; Abe M; Katoh T; Ohtsuka N
    Lipids Health Dis; 2011 May; 10():79. PubMed ID: 21586120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
    Meis SB; Schuster D; Gaillard T; Osei K
    Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimarker Assessment of Diastolic Dysfunction in Metabolic Syndrome Patients.
    Mocan M; Anton F; Suciu Ș; Răhăian R; Blaga SN; Fărcaș AD
    Metab Syndr Relat Disord; 2017 Dec; 15(10):507-514. PubMed ID: 29099655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.